Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedEditorial updates clarify PubMed auto-fill and update the revision tag to v3.3.2 (from v3.2.0); these are minor wording changes that do not affect trial content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now lists related topics Lung cancer and MedlinePlus Genetics. The government funding notice about potential delays has been removed.SummaryDifference0.2%

- Check25 days agoChange DetectedUpdated the Taiwan site entry for code 704 from 'Tainan City' to 'Tainan'.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page appears to have a visual/layout update without changes to core study details like criteria, outcomes, or locations.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Lung cancer, reducing genetics content coverage on that disease.SummaryDifference0.1%

- Check61 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.